Efficacy of daratumumab as monotherapy or in combination with antitumor drugs in patients with relapsed / refractory multiple myeloma depending on the previous chemotherapy lines number - PDF (Russian)


Copyright (c) 2025 ABV-press

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36928 от  21.07.2009.

The website of the journal Oncohematology contains materials intended exclusively for healthcare professionals.

By closing this message, you confirm* that you are a licensed healthcare professional or a student of a medical educational institution.

This one-time confirmation is valid for the next 30 days.